Massive GERD study tracks which treatment works best Long-Term
NCT ID NCT00260572
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 2,500 people with gastroesophageal reflux disease (GERD) to compare how well medications and surgery work over time. Researchers will track quality of life, heartburn symptoms, and patient satisfaction. The goal is to identify who benefits most from each treatment and why some treatments fail.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict which GERD patients will benefit most from surgery versus medication.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test a new therapy, so results may not change current practice immediately.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL REFLUX DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UPMC Department of Cardiothoracic Surgery
Pittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a tailored diet quiet the burn of acid reflux?
- Can surgery offer lasting relief for chronic heartburn? a large registry investigates
- Can big data unlock better GERD treatment for chinese patients?
- Which Anti-Reflux surgery is kinder to a Child's stomach?
- Single-Port robot could make pediatric surgery less invasive
- Mindfulness app may soothe heartburn and anxiety in GERD patients